IP Library Granted Patent US 10,464,994
Granted Patent B2
US 10,464,994 · App. 14/957,030 · Granted Nov 5, 2019

Recombinant clusterin and use thereof in the treatment and prevention of disease

Inventor: Yong-Jian Geng (Houston, TX)
Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
C07K14/775A61K9/0019A61K9/19A61K38/00C07K2319/00C07K2319/21C07K2319/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,464,994
App. No.
14/957,030
Granted
Nov 5, 2019
Kind
B2
Abstract

Recombinant clusterin polypeptides and compositions comprising the same are provided. In some aspects, recombinant clusterin or nucleic acids encoding the same may be used for treating and preventing an abnormality of morphology and function in a mammal with disease (e.g., cardiovascular diseases or alcoholism).

Claims (15)

1. A recombinant polypeptide comprising a Clusterin coding sequence, said coding sequence having at least 95% sequence identity to SEQ ID NO: 3, said sequence not including the Clusterin nuclear localization signal sequence (LEEAKKKK; SEQ ID NO: 27) and not including the Clusterin transmembrane domain sequence (LLLFVGLLL; SEQ ID NO: 28).

2. The polypeptide of claim 1 , comprising a Clusterin coding sequence having at least 98% sequence identity to SEQ ID NO:3.

3. The polypeptide of claim 1 , further comprising a heterologous polypeptide sequence fused to said Clusterin coding sequence.

4. The polypeptide of claim 3 , wherein the heterologous polypeptide sequence comprises a protease cleavage site.

5. The polypeptide of claim 3 , wherein the protease cleavage site is a thrombin cleavage site.

6. The polypeptide of claim 1 , wherein the polypeptide is aglycosylated.

7. The polypeptide of claim 1 , further comprising a tag sequence.

8. The polypeptide of claim 7 , further comprising a protease cleavage site positioned between the tag sequence and the clusterin coding sequence.

9. The polypeptide of claim 7 , wherein the protease cleavage site is a thrombin or enteropeptidase cleavage site.

10. The polypeptide of claim 7 , wherein the tag sequence is a polyhistidine tag.

11. The polypeptide of claim 7 , wherein the tag sequence is positioned N-terminally relative to the Clusterin coding sequence.

12. The polypeptide of claim 7 , wherein the tag sequence is positioned C-terminally relative to the Clusterin coding sequence.

13. A composition comprising a polypeptide of claim 1 in a pharmaceutically acceptable carrier.

14. An isolated polynucleotide molecule comprising a nucleic acid sequence encoding a polypeptide of claim 1 .

15. A host cell comprising a polynucleotide molecule encoding a polypeptide of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2016
From: GENG, YONG-JIAN
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 038499/0036 →
Continuity (2)
Provisional Application 62087364 · Dec 4, 2014
Related Publication 20160222088A1 · Aug 4, 2016